Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial

The neuropeptide oxytocin has shown promise as a treatment for symptoms of autism spectrum disorders (ASD). However, clinical research progress has been hampered by a poor understanding of oxytocin’s dose–response and sub-optimal intranasal delivery methods. We examined two doses of oxytocin deliver...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintana, D S, Westlye, L T, Hope, S, Nærland, T, Elvsåshagen, T, Dørum, E, Rustan, Ø, Valstad, M, Rezvaya, L, Lishaugen, H, Stensønes, E, Yaqub, S, Smerud, K T, Mahmoud, R A, Djupesland, P G, Andreassen, O A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584522/
https://www.ncbi.nlm.nih.gov/pubmed/28534875
http://dx.doi.org/10.1038/tp.2017.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584522/
https://www.ncbi.nlm.nih.gov/pubmed/28534875
http://dx.doi.org/10.1038/tp.2017.103

Ejemplares similares